TCR-Therapy Pipeline Research Report 2023: Comprehensive Insights on 30+ Companies and 100+ Pipeline Drugs
November 22, 2023 08:48 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "TCR-Therapy - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Rising Prevalence of Acute Lymphocytic Leukemia Drives T-Cell Therapy Market: With Johnson & Johnson, AbbVie, Amgen, Novartis, Sorrento, Pfizer Dominating
August 21, 2023 07:23 ET
|
Research and Markets
Dublin, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication...
Insights on the T-Cell Therapy Global Market to 2035 - by Type of Therapy, Target Indications, Target Antigens and Geography
January 04, 2023 05:28 ET
|
Research and Markets
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell Therapy Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key Players and Key Geographies: Industry Trends...
Global TCR Therapy Pipeline Landscape Opportunity Assessment 2021: Companies, Drugs, Therapeutics, Phases, Trends and Outlook
December 16, 2021 10:08 ET
|
Research and Markets
Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "TCR Therapy - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...
Global T-Cell Therapies Market Report 2021: Type of Therapy, Target Indications, Target Antigens, Key Players and Key Regions 2020-2030
February 19, 2021 04:33 ET
|
Research and Markets
Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "Global T-Cell Therapies Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key Players and Key Regions: Industry Trends and...